Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-06-01

Clinical Trial Update: Conventional Versus Hypofractionated Radiotherapy in Node Positive Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing conventional versus hypofractionated radiotherapy in node-positive breast cancer; status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ain Shams University | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN